Ajax-Loading

Novartis AG - Capital Lease Obligations

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Capital-Lease-Obligations" stands at 1.90 Billion United States Dollars as of 09/30/2025, the highest value since 09/30/2021.

As of the end of Novartis AG's third quarter, the item "Capital Lease Obligations" stands at 1.90 Billion USD. This represents an increase of 2.75 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.31 percent compared to the value the year prior.
The 1 year change in percent is 3.31.
The 3 year change in percent is 8.74.
The 5 year change in percent is -2.41.

The Serie's long term average value is 1.87 Billion United States Dollars. It's latest available value, on 09/30/2025, is 1.83 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2023, to it's latest available value, on 09/30/2025, is +14.49%.
The Serie's change in percent from it's maximum value, on 06/30/2019, to it's latest available value, on 09/30/2025, is -6.94%.

Capital Lease Obligations for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Capital Lease Obligations905,699,262,464.00
LogoJohnson & Johnson - Capital Lease Obligations486,508,953,600.00
LogoAbbVie Inc - Capital Lease Obligations399,570,305,024.00
LogoRoche Holding AG - Capital Lease Obligations317,433,206,677.55
LogoAstraZeneca PLC - Capital Lease Obligations280,205,508,085.11